Pharmaceutical Preparations - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Pharmaceutical industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Pharmaceutical Preparations - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Pharmaceutical Preparations
Corporate Insider Buy Sell Ratio (Insider Count) - Pharmaceutical Preparations
Pharmaceutical Preparations - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-06-05 EQ / Equillium, Inc. 4 Zedelmayer Christine S - Sale D 2.9304 -14,584
2026-06-05 CVKD / Cadrenal Therapeutics, Inc. 4 Pham Quang X S - Sale D 4.42 -2,064
2026-06-05 EQ / Equillium, Inc. 4 Connelly Stephen S - Sale D 2.9401 -30,975
2026-06-05 INSM / Insmed Incorporated 4 Flammer Martina M.D. S - Sale D 103.78 -1,858
2026-06-05 EQ / Equillium, Inc. 4 Zedelmayer Christine M - Exercise D 0.785 14,584
2026-06-05 PTPI / Petros Pharmaceuticals, Inc. 4 Silverman Joshua A - Award D 4,375,000
2026-06-05 PTPI / Petros Pharmaceuticals, Inc. 4 Boctor Fady A - Award D 375,000
2026-06-05 PTPI / Petros Pharmaceuticals, Inc. 4 Bernstein Bruce A - Award D 1,875,000
2026-06-04 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 539.5134 -120
2026-06-04 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 541.0837 -473
2026-06-04 PCRX / Pacira BioSciences, Inc. 4 Williams Kristen Marie S - Sale D 22.27 -10,259
2026-06-04 CVKD / Cadrenal Therapeutics, Inc. 4 Pham Quang X S - Sale D 4.41 -3,898
2026-06-04 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 545.1824 -1,186
2026-06-04 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 542.4962 -112
2026-06-04 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 550.46 -560
2026-06-04 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 549.2436 -780
2026-06-04 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 546.4178 -2,627
2026-06-04 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 549.4948 -593
2026-06-04 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 539.76 -200
2026-06-04 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 549.47 -1,250
2026-06-04 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 545.2671 -374
2026-06-04 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 547.1108 -935
2026-06-04 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 543.109 -396
2026-06-04 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 548.425 -1,481
2026-06-04 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 544.2432 -1,470
2026-06-04 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 548.2638 -1,676
2026-06-04 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 546.1435 -1,202
2026-06-04 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 543.8893 -840
2026-06-04 XERS / Xeris Biopharma Holdings, Inc. 4 BORMANN-KENNEDY BARBARA-JEAN ANNE S - Sale D 6.0942 -16,000
2026-06-04 EQ / Equillium, Inc. 4 Connelly Stephen S - Sale D 3.1638 -200,000
2026-06-04 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 547.5256 -1,525
2026-06-04 KROS / Keros Therapeutics, Inc. 4 Seth Alpna S - Sale D 10.72 -2,625
2026-06-04 UTHR / United Therapeutics Corporation 4 EDGEMOND JAMES S - Sale D 542.7769 -440
2026-06-04 UTHR / United Therapeutics Corporation 4 EDGEMOND JAMES S - Sale D 550.4767 -120
2026-06-04 UTHR / United Therapeutics Corporation 4 EDGEMOND JAMES S - Sale D 544.9442 -1,545
2026-06-04 UTHR / United Therapeutics Corporation 4 EDGEMOND JAMES S - Sale D 545.8885 -1,129
2026-06-04 UTHR / United Therapeutics Corporation 4 EDGEMOND JAMES S - Sale D 541.1433 -480
2026-06-04 UTHR / United Therapeutics Corporation 4 EDGEMOND JAMES S - Sale D 544.1119 -1,086
2026-06-04 UTHR / United Therapeutics Corporation 4 EDGEMOND JAMES S - Sale D 547.0035 -1,033
2026-06-04 UTHR / United Therapeutics Corporation 4 EDGEMOND JAMES S - Sale D 548.0374 -2,749
2026-06-04 UTHR / United Therapeutics Corporation 4 EDGEMOND JAMES S - Sale D 549.0586 -1,298
2026-06-04 XERS / Xeris Biopharma Holdings, Inc. 4 JOHNSON JOHN S - Sale D 6.0948 -15,000
2026-06-04 UTHR / United Therapeutics Corporation 4 EDGEMOND JAMES S - Sale D 539.6393 -120
2026-06-04 ALKS / Alkermes plc 4 Gaffin David Joseph S - Sale D 43.05 -2,034
2026-06-04 XERS / Xeris Biopharma Holdings, Inc. 4 HALKUFF DAWN S - Sale D 6.0943 -20,000
2026-06-04 SMMT / Summit Therapeutics Inc. 4 Zanganeh Maky By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee P - Purchase I 14.60 100,000
2026-06-04 PRTA / Prothena Corporation plc 4 SCULLY WILLIAM P P - Purchase D 9.3059 50,000
2026-06-04 SMMT / Summit Therapeutics Inc. 4 DUGGAN ROBERT W By the Mahkam Zanganeh Revocable Trust, with the Spouse of Reporting Person as Trustee P - Purchase I 14.60 100,000
2026-06-04 SMMT / Summit Therapeutics Inc. 4 Soni Manmeet Singh P - Purchase D 14.43 25,000
2026-06-04 SMMT / Summit Therapeutics Inc. 4 Soni Manmeet Singh P - Purchase D 14.46 25,000
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)